New building in Singapore is home of region's largest clinical development
RESEARCH TRIANGLE PARK, N.C., Sept. 10 /PRNewswire/ -- Quintiles Transnational Corp. announced today that it will expand its Singapore operations to meet the surging demand for its business in the Asia-Pacific region. The new regional headquarters will be double the size of its existing presence in Singapore and will be the home of the region's largest clinical development organization. Quintiles' Asia-Pacific growth also has led to expansion of seven local offices in the region and the addition of a new location in Indonesia.
"Quintiles is the largest and fastest growing clinical development group in Asia," said Dennis Gillings, CBE, Chairman and Chief Executive Officer. "Since entering the region in the 1990s, we have built a strong staff of 2,800 clinical development professionals, representing a total of 23 nationalities, who have worked in more clinical trials and with more investigator sites than any other single organization in Asia."
Anand Tharmaratnam, M.D., Head of Clinical Development, Quintiles Asia Pacific, said the expanded facility renews the company's commitment to the region and to its partnership with the Singapore Economic Development Board (EDB).
"Our growth in Singapore has been bolstered by the expanding base of companies and research institutes in Singapore's larger biomedical sciences research community," Tharmaratnam said. "We are projecting continued strong growth in the future, and this new facility gives us the room we will need. The new location also will allow us to work more efficiently, share best practices and deliver truly turnkey solutions to our customers."
"Quintiles was the first contract research organization to set up
operations here. Its continued growth since the mid 1990s is testament to
Singapore's attractiveness as a home base from which contract research
|SOURCE Quintiles Transnational Corp.|
Copyright©2008 PR Newswire.
All rights reserved